1. Government of Canada. Canadian Tobacco, Alcohol and Drugs Survey (CTADS): summary of results for 2017. https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2017-summary.html2019.
2. Government of Canada. A Framework for the Legalization and Reguation of Cannabis in Canada. Ottawa, ON: Health Canada; 2016.
3. Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317(2):207-9.
4. Finnegan L. Substance abuse in Canada: Licit and illicit drug use during pregnancy: Maternal, neonatal and early childhood consequences. Ottawa, ON: Canadian Centre on Substance Abuse; 2013.
5. Varner MW, Silver RM, Hogue CJR, Willinger M, Parker CB, Thorsten VR, et al. Association Between Stillbirth and Illicit Drug Use and Smoking During Pregnancy. Obstetrics and gynecology. 2014;123(1):113-25.
6. Saurel-Cubizolles MJ, Prunet C, Blondel B. Cannabis use during pregnancy in France in 2010. BJOG: An International Journal of Obstetrics & Gynaecology. 2014;121(8):971-7.
7. Leemaqz SY, Dekker GA, McCowan LM, Kenny LC, Myers JE, Simpson NAB, et al. Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reproductive Toxicology. 2016;62:77-86.
8. Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215-9.
9. Fergusson DM, Horwood LJ, Northstone K, Team AS. Maternal use of cannabis and pregnancy outcome. BJOG: An International Journal of Obstetrics & Gynaecology. 2002;109(1):21-7.
10. El Marroun H, Tiemeier H, Steegers EAP, Jaddoe VWV, Hofman A, Verhulst FC, et al. Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study. Journal of the American Academy of Child & Adolescent Psychiatry. 2009;48(12):1173-81.
11. Conner SN, Bedell V, Lipsey K, Macones GA, Cahill AG, Tuuli MG. Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis. Obstetrics & Gynecology. 2016;128(4):713-23.
12. Gunn JKL, Rosales CB, Center KE, Nuñez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986.
13. Witter FR, Niebyl JR. Marijuana Use in Pregnancy and Pregnancy Outcome. Amer J Perinatol. 1990;7(01):36-8.
14. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States. Biol Psychiatry. 2016;79(7):613-9.
15. Hayes JS, Lampart R, Dreher MC, Morgan L. Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. West Indian Med J. 1991;40(3):120-3.
16. McLemore GL, Richardson KA. Data from three prospective longitudinal human cohorts of prenatal marijuana exposure and offspring outcomes from the fetal period through young adulthood. Data in Brief. 2016;9:753-7.
17. Dunn S, Bottomley J, Ali A, Walker M. 2008 Niday Perinatal Database quality audit: report of a quality assurance project. Chronic Dis Inj Can. 2011;32(1):32-42.
18. Janus M, Offord D. Readiness to learn at school. Canadian Journal of Policy Research. 2000;1(2):71-5.
19. Janus M, Offord DR. Development and psychometric properties of the Early Development Instrument (EDI): A measure of children's school readiness. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement. 2007;39(1):1.
20. Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. American Journal of Obstetrics & Gynecology. 2015;213(2):201.e1-.e10.
21. Gelder MMHJvR, Jennita; Caton, Alissa R; Werler, Martha M; Druschel, Charlotte M; Roeleveld, Nel. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology. 2009;20 1:60-6.
22. Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;9(1):1-7.
23. Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. Journal of developmental and behavioral pediatrics : JDBP. 1990;11(2):49-58.
24. Fried PA, O'Connell CM, Watkinson B. 60- and 72-month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment. Journal of developmental and behavioral pediatrics : JDBP. 1992;13(6):383-91.
25. Fried PA, Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2001;23(5):421-30.
26. Corsi DJ, Davey Smith G, Subramanian SV. Commentary: challenges to establishing the link between birthweight and cognitive development. Int J Epidemiol. 2013;42(1):172-5.
27. Porath AJ, Fried PA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicology and Teratology. 2005;27(2):267-77.
28. Day N, Sambamoorthi U, Taylor P, Richardson G, Robles N, Jhon Y, et al. Prenatal marijuana use and neonatal outcome. Neurotoxicology and Teratology. 1991;13(3):329-34.
29. Day NL, Richardson GA, Goldschmidt L, Robles N, Taylor PM, Stoffer DS, et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicology and Teratology. 1994;16(2):169-75.
30. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years. Neurotoxicology and Teratology. 2002;24(3):309-20.
31. El Marroun H, Hudziak JJ, Tiemeier H, Creemers H, Steegers EAP, Jaddoe VWV, et al. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug & Alcohol Dependence. 2011;118(2):470-4.
32. Richardson KA, Hester AK, McLemore GL. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system. Neurotoxicol Teratol. 2016;58:5-14.
33. Friedrich J, Khatib D, Parsa K, Santopietro A, Gallicano GI. The grass isn't always greener: The effects of cannabis on embryological development. BMC Pharmacol Toxicol. 2016;17(1):45.
34. Correa F, Wolfson ML, Valchi P, Aisemberg J, Franchi AM. Endocannabinoid system and pregnancy. Reproduction. 2016;152(6):R191-R200.
35. Institute for Clinical Evaluative Sciences. Data Repository 2017 [August 17,2017]. Available from: https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx.
36. Canadian Institute for Health Information. Discharge Abstract Database - Multiyear Information. 2012.
37. Heckman J. Invest in early childhood development: educe deficits, strengthen the economy. Heckman: The Economics of Human Potential Available at: http://wwwheckmanequationorg/heckman-equation. 2012.
38. Psacharopoulos G, Arriagada AM. The determinants of early age human capital formation: Evidence from Brazil. Economic development and cultural Change. 1989;37(4):683-708.
39. Nandi A, Bhalotra S, Deolalikar AB, Laxminarayan R. The Human Capital and Productivity Benefits of Early Childhood Nutritional Interventions. In: rd, Bundy DAP, Silva N, Horton S, Jamison DT, Patton GC, editors. Child and Adolescent Health and Development. Washington (DC)2017.
40. Davies S, Janus M, Duku E, Gaskin A. Using the Early Development Instrument to examine cognitive and non-cognitive school readiness and elementary student achievement. Early Childhood Research Quarterly. 2016;35:63-75.
41. Janus M, editor Early Development Instrument: An indicator of developmental health at school entry. International Conference on Measuring Early Child Development Vaudreuil, Quebec; 2006.
42. Forer B, Zumbo BD. Validation of multilevel constructs: Validation methods and empirical findings for the EDI. Social Indicators Research. 2011;103(2):231.
43. Lloyd JE, Hertzman C. From kindergarten readiness to fourth-grade assessment: Longitudinal analysis with linked population data. Social science & medicine. 2009;68(1):111-23.
44. Janus M, Brinkman SA, Duku EK. Validity and psychometric properties of the early development instrument in Canada, Australia, United States, and Jamaica. Social Indicators Research. 2011;103(2):283.
45. Brinkman S, Gregory T, Harris J, Hart B, Blackmore S, Janus M. Associations between the early development instrument at age 5, and reading and numeracy skills at ages 8, 10 and 12: a prospective linked data study. Child Indicators Research. 2013;6(4):695-708.
46. O'Leary JD, Janus M, Duku E, Wijeysundera DN, To T, Li P, et al. A Population-based Study Evaluating the Association between Surgery in Early Life and Child Development at Primary School Entry. Anesthesiology. 2016;125(2):272-9.
47. Fell DB, Wilson K, Ducharme R, Hawken S, Sprague AE, Kwong JC, et al. Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination. PLoS One. 2016;11(8):e0160342.
48. Better Outcomes Registry & Network (BORN) Ontario. Annual Report 2012–2013 and 2013–2014. Ottawa, Ontario; 2015.
49. Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children. JAMA. 2017;317(15):1544-52.
50. Burke JP, Jain A, Yang W, Kelly JP, Kaiser M, Becker L, et al. Does a claims diagnosis of autism mean a true case? Autism. 2014;18(3):321-30.
51. Frenette P, Dodds L, MacPherson K, Flowerdew G, Hennen B, Bryson S. Factors affecting the age at diagnosis of autism spectrum disorders in Nova Scotia, Canada. Autism. 2013;17(2):184-95.
52. Perou R, Bitsko RH, Blumberg SJ, Pastor P, Ghandour RM, Gfroerer JC, et al. Mental health surveillance among children--United States, 2005-2011. MMWR Suppl. 2013;62(2):1-35.
53. Bardach NS, Coker TR, Zima BT, Murphy JM, Knapp P, Richardson LP, et al. Common and costly hospitalizations for pediatric mental health disorders. Pediatrics. 2014;133(4):602-9.
54. Steele LS, Glazier RH, Lin E, Evans M. Using administrative data to measure ambulatory mental health service provision in primary care. Med Care. 2004;42(10):960-5.
55. Gandhi S, Chiu M, Lam K, Cairney JC, Guttmann A, Kurdyak P. Mental Health Service Use Among Children and Youth in Ontario: Population-Based Trends Over Time. Can J Psychiatry. 2016;61(2):119-24.
56. Yang T, Walker MC, Krewski D, Yang Q, Nimrod C, Garner P, et al. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008;17(3):270-7.
57. Wen SW, Yang T, Krewski D, Yang Q, Nimrod C, Garner P, et al. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol. 2008;28(5):324-9.
58. Corsi DJ, Lear SA, Chow CK, Subramanian SV, Boyle MH, Teo KK. Socioeconomic and geographic patterning of smoking behaviour in Canada: a cross-sectional multilevel analysis. PLoS One. 2013;8(2):e57646.
59. Corsi DJ, Lippert AM. An examination of the shift in school-level clustering of US adolescent electronic cigarette use and its multilevel correlates, 2011-2013. Health Place. 2016;38:30-8.
60. Luo ZC, Wilkins R, Kramer MS, Fetal, Infant Health Study Group of the Canadian Perinatal Surveillance System. Effect of neighbourhood income and maternal education on birth outcomes: a population-based study. CMAJ. 2006;174(10):1415-20.
61. Vogel JP, Lee AC, Souza JP. Maternal morbidity and preterm birth in 22 low- and middle-income countries: a secondary analysis of the WHO Global Survey dataset. BMC Pregnancy Childbirth. 2014;14:56.
62. Currie J, Schwandt H. Within-mother analysis of seasonal patterns in health at birth. Proc Natl Acad Sci U S A. 2013;110(30):12265-70.
63. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512-22.
64. Guertin JR, Rahme E, LeLorier J. Performance of the high-dimensional propensity score in adjusting for unmeasured confounders. Eur J Clin Pharmacol. 2016;72(12):1497-505.
65. Lawlor DA, Tilling K, Davey Smith G. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016;45(6):1866-86.
66. Saccone G, Berghella V. Folic acid supplementation in pregnancy to prevent preterm birth: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2016;199:76-81.
67. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661-79.